Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katrin Benzler"'
Autor:
Mary E. Carter, Alessia Benegiamo-Chilla, Linus D. Kloker, Nikolas Paulsen, Vlatko Potkrajcic, Frank Paulsen, Attila Nemeth, Volker Steger, Martin Schulze, Saskia Biskup, Katrin Benzler, Stephan Singer, Ulrich M. Lauer, Lars Zender, Christoph K. W. Deinzer
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Ewing sarcoma is the second most common primary malignant bone cancer in children and adolescents. This rare type of cancer is characterized by its high malignancy and therefore high risk of metastases. Typically, Ewing sarcomas originate from bones.
Externí odkaz:
https://doaj.org/article/5dbcb53fcef34475aac759e77dd87a55
Autor:
Linus D. Kloker, Branko Calukovic, Katrin Benzler, Alexander Golf, Sebastian Böhm, Sven Günther, Marius Horger, Simone Haas, Susanne Berchtold, Julia Beil, Mary E. Carter, Tina Ganzenmueller, Stephan Singer, Abbas Agaimy, Robert Stöhr, Arndt Hartmann, Thomas Duell, Sandra Mairhofer, Fabian Fohrer, Niels Reinmuth, Lars Zender, Ulrich M. Lauer
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
NUT carcinoma (NC) is a rare and extremely aggressive form of cancer, usually presenting with intrathoracic or neck manifestations in adolescents and young adults. With no established standard therapy regimen and a median overall survival of only 6.5
Externí odkaz:
https://doaj.org/article/937409fb0e814f379cae06b3619b90ce
Autor:
Hinterleitner, Moritz Schmidt, Katrin Benzler, Ulrich M. Lauer, Lars Zender, Clemens Hinterleitner, Martina
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 19; Pages: 5798
Sarcomas compromise a heterogenous group of tumors of a mesenchymal origin. Although treatment options in many solid tumors have evolved over the past decades, the treatment of advanced sarcoma is still based on conventional chemotherapeutic agents.
Autor:
Moritz, Schmidt, Katrin, Benzler, Ulrich M, Lauer, Lars, Zender, Clemens, Hinterleitner, Martina, Hinterleitner
Publikováno v:
Journal of clinical medicine. 11(19)
Sarcomas compromise a heterogenous group of tumors of a mesenchymal origin. Although treatment options in many solid tumors have evolved over the past decades, the treatment of advanced sarcoma is still based on conventional chemotherapeutic agents.
Autor:
Stefan S. Bielack, Lars H. Lindner, Gerlinde Egerer, Katrin Benzler, Claudia Blattmann, Matthias Grube, Dennis Hahn, Leo Kager, Thomas Kühne, Vanessa Mettmann, Peter Reichardt, Stefanie Hecker-Nolting
Publikováno v:
Journal of Geriatric Oncology. 14:101445